PR Newswire | Dec 18, 2020 01:25PM EST

12/18 12:25 CST

TMX Group, Avivagen, C-Suite at The Open TORONTO, Dec. 18, 2020

TORONTO, Dec. 18, 2020 /CNW/ - Kym Anthony, CEO, Avivagen Inc. (TSXV: VIV), shares his company's story in aninterview with TMX Group.

The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html.

About Avivagen Inc. (TSXV: VIV)

Avivagen Inc. is a Canadian based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's own health defenses. Its product range includes OxC-beta, Vivamune health chews, Oximunol chewable tablets, and Carotenoid Oxidation products. For more information visit: http://www.avivagen.com/

About TMX Group (TSX: X)

TMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montral Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montral, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup.

SOURCE TMX Group Limited